A BILL 
To amend the market name of genetically altered salmon 
in the United States, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Genetically Engineered 
4
Salmon Labeling Act’’. 
5
SEC. 2. PURPOSES. 
6
It is the purpose of this Act to— 
7
(1) ensure that consumers in the United States 
8
can make informed decisions when purchasing salm-
9
on; and 
10
05:46 Feb 05, 2021
H270
2 
•HR 270 IH
(2) authorize an independent scientific review 
1
of— 
2
(A) the possible effects of genetically engi-
3
neered salmon on wild salmon stocks; and 
4
(B) the Food and Drug Administration’s 
5
approval of genetically engineered salmon for 
6
human consumption. 
7
SEC. 3. MARKET NAME FOR GENETICALLY ENGINEERED 
8
SALMON. 
9
(a) IN GENERAL.—Notwithstanding any other provi-
10
sion of law, for purposes of applying the Federal Food, 
11
Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), the ac-
12
ceptable market name of any salmon that is genetically 
13
engineered shall include the words ‘‘Genetically Engi-
14
neered’’ or ‘‘GE’’ prior to the existing acceptable market 
15
name. 
16
(b) DEFINITION.—For purposes of this section, salm-
17
on is genetically engineered if it has been modified by re-
18
combinant DNA (rDNA) techniques, including the entire 
19
lineage of salmon that contain the rDNA modification. 
20
SEC. 4. THIRD-PARTY REVIEW OF CERTAIN SALMON AP-
21
PROVAL. 
22
The Secretary of Health and Human Services shall 
23
ensure that an independent scientific organization con-
24
ducts a review of the environmental assessment that was 
25
05:46 Feb 05, 2021
H270
3 
•HR 270 IH
carried out by the Food and Drug Administration in sup-
1
port of an approval of a new animal drug application re-
2
lated to AquAdvantage Salmon, dated November 12, 
3
2015. 
4
Æ 
05:46 Feb 05, 2021
H270
